IDYA IDEAYA BIOSCIENCES INC revenue, earnings and financials

For the quarter ended June 30, 2026, IDEAYA BIOSCIENCES INC reported revenue of $8.86M, net income of −$112M and diluted EPS of −$1.22; for the fiscal year ended December 2025 revenue was $219M, up 3024.4% on the year before.

IDYA annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $219M, gross profit n/a, operating income −$159M, net income −$114M (margin -52.0%), EPS −$1.28
• Fiscal year ended Dec 2024: revenue $7.00M, gross profit n/a, operating income −$327M, net income −$274M (margin -3921.1%), EPS −$3.36
• Fiscal year ended Dec 2023: revenue $23.4M, gross profit n/a, operating income −$134M, net income −$113M (margin -483.0%), EPS −$1.96
• Fiscal year ended Dec 2022: revenue $50.9M, gross profit n/a, operating income −$62.5M, net income −$58.7M (margin -115.2%), EPS −$1.42
• Fiscal year ended Dec 2021: revenue $27.9M, gross profit n/a, operating income −$50.3M, net income −$49.8M (margin -178.1%), EPS −$1.41

IDYA quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $8.86M, net income −$112M, EPS −$1.22
• Quarter ended Mar 31, 2026: revenue $6.56M, net income −$98.5M, EPS −$1.11
• Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$83.3M, EPS −$0.91
• Quarter ended Sep 30, 2025: revenue $208M, net income $119M, EPS $1.33
• Quarter ended Jun 30, 2025: revenue n/a, net income −$77.5M, EPS −$0.88
• Quarter ended Mar 31, 2025: revenue n/a, net income −$72.2M, EPS −$0.82
• Quarter ended Dec 31, 2024 (from the annual report): revenue $7.00M (up 78.4% year over year), net income −$130M, EPS −$1.55
• Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$51.8M, EPS −$0.60
• Quarter ended Jun 30, 2024: revenue $0 (down 100.0% year over year), net income −$52.8M, EPS −$0.68
• Quarter ended Mar 31, 2024: revenue $0 (down 100.0% year over year), net income −$39.6M, EPS −$0.53
• Quarter ended Dec 31, 2023 (from the annual report): revenue $3.92M (down 2.5% year over year), net income −$34.0M, EPS −$0.51
• Quarter ended Sep 30, 2023: revenue $8.04M (down 72.9% year over year), net income −$27.4M, EPS −$0.46
• Quarter ended Jun 30, 2023: revenue $3.54M (down 39.4% year over year), net income −$27.9M, EPS −$0.50
• Quarter ended Mar 31, 2023: revenue $7.88M (down 30.6% year over year), net income −$23.6M, EPS −$0.49
• Quarter ended Dec 31, 2022 (from the annual report): revenue $4.02M (up 35.8% year over year), net income −$24.2M, EPS −$0.53
• Quarter ended Sep 30, 2022: revenue $29.7M (up 230.9% year over year), net income $1.62M, EPS $0.04
• Quarter ended Jun 30, 2022: revenue $5.85M (down 33.2% year over year), net income −$22.1M, EPS −$0.57
• Quarter ended Mar 31, 2022: revenue $11.4M (up 56.7% year over year), net income −$14.0M, EPS −$0.36
• Quarter ended Dec 31, 2021 (from the annual report): revenue $2.96M, net income −$18.2M, EPS −$0.49
• Quarter ended Sep 30, 2021: revenue $8.98M, net income −$11.6M, EPS −$0.31

IDYA cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$71.1M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$248M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$115M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$87.2M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$55.8M, share buybacks n/a

IDYA balance sheet

• Jun 30, 2026: cash $273M, total assets $1.31B, total liabilities $111M, shareholders' equity $1.20B
• Mar 31, 2026: cash $158M, total assets $1.03B, total liabilities $93.1M, shareholders' equity $937M
• Dec 31, 2025: cash $113M, total assets $1.11B, total liabilities $86.4M, shareholders' equity $1.02B
• Sep 30, 2025: cash $299M, total assets $1.19B, total liabilities $93.1M, shareholders' equity $1.09B
• Jun 30, 2025: cash $115M, total assets $1.04B, total liabilities $81.6M, shareholders' equity $960M
• Mar 31, 2025: cash $130M, total assets $1.10B, total liabilities $76.5M, shareholders' equity $1.02B
• Dec 31, 2024: cash $84.4M, total assets $1.12B, total liabilities $64.9M, shareholders' equity $1.06B
• Sep 30, 2024: cash $400M, total assets $1.24B, total liabilities $59.5M, shareholders' equity $1.18B

What is IDYA's revenue?

IDEAYA BIOSCIENCES INC reported $219M of revenue for the fiscal year ended December 2025.

Is IDYA profitable?

No. IDEAYA BIOSCIENCES INC lost $175M over the last four quarters.

What is IDYA's EPS?

Diluted earnings per share over the last four quarters were −$1.91; −$1.22 in the latest quarter.

IDYA ownership and insider trades · All stocks